Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19
Public ClinicalTrials.gov record NCT04365101. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase I/II Study of Human Placental Hematopoietic Stem Cell Derived Natural Killer Cells (CYNK-001) for the Treatment of Adults With COVID-19
Study identification
- NCT ID
- NCT04365101
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- Celularity Incorporated
- Industry
- Enrollment
- 86 participants
Conditions and interventions
Conditions
- ARDS
- Analgesics
- Anti-infective Agents
- Antimetabolites, Antineoplastic
- Antiviral Agents
- Coronaviridae Infections
- Coronavirus
- Coronavirus Infection
- Immunologic Disease
- Immunologic Factors
- Lung Diseases
- Nidovirales Infections
- Physiological Effects of Drugs
- Pneumonia
- Pneumonia, Viral
- RNA Virus Infections
- Respiratory Tract Disease
- Respiratory Tract Infections
- Severe Acute Respiratory Syndrome Coronavirus 2
- Virus Disease
Interventions
- CYNK-001 Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 12, 2020
- Primary completion
- Dec 29, 2021
- Completion
- Jun 29, 2022
- Last update posted
- May 24, 2022
2020 – 2022
United States locations
- U.S. sites
- 7
- U.S. states
- 3
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UC Irvine | Irvine | California | 92697 | — |
| UC Davis Medical Center | Sacramento | California | 95817 | — |
| Scripps Health | San Diego | California | 92121 | — |
| Hackensack University Medical Center | Hackensack | New Jersey | 07601 | — |
| Atlantic Health | Morristown | New Jersey | 07960 | — |
| Atlantic Health | Summit | New Jersey | 07901 | — |
| Multicare Health System | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04365101, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 24, 2022 · Synced May 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04365101 live on ClinicalTrials.gov.